Who owns PASITHEA THERAPEUTICS CORP?
- Ticker: KTTA
- CUSIP Number: 70261f202
Tip: Access positions for across all investors
Analyze quarterly positions in Pasithea Therapeutics Corp with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pasithea Therapeutics Corp stock
Who bought or sold PASITHEA THERAPEUTICS CORP this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| ADAR1 Capital Management | 28k | $201k | 100% | Mar 2024 |
|
| Tower Research Capital | 1.8k | $9.1k | 34% | Jun 2024 |
|
| UBS Group | 608.00 | $4.4k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 250.00 | $1.0k | 0% | Jun 2024 |
|
| Jpmorgan Chase & Co | 150.00 | $784.995000 | 0% | Jun 2024 |
|
| Bank of America Corporation | 6.00 | $30.000000 | 100% | Jun 2024 |
|
Who sold out of Pasithea Therapeutics Corp?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Wells Fargo & Company | Mar 2024 | 6.00 | $43.999800 |